297 related articles for article (PubMed ID: 9483158)
1. Implications of socio-cultural contexts for the ethics of clinical trials.
Ashcroft RE; Chadwick DW; Clark SR; Edwards RH; Frith L; Hutton JL
Health Technol Assess; 1997; 1(9):i-iv, 1-65. PubMed ID: 9483158
[TBL] [Abstract][Full Text] [Related]
2. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
3. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials in the new millennium.
DeMets DL
Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093
[TBL] [Abstract][Full Text] [Related]
5. What makes placebo-controlled trials unethical?
Miller FG; Brody H
Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
[TBL] [Abstract][Full Text] [Related]
6. Are distinctive ethical principles required for cluster randomized controlled trials?
Hutton JL
Stat Med; 2001 Feb; 20(3):473-88. PubMed ID: 11180314
[TBL] [Abstract][Full Text] [Related]
7. Ethical pitfalls in neonatal comparative effectiveness trials.
Modi N
Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
[TBL] [Abstract][Full Text] [Related]
8. Using routine data to complement and enhance the results of randomised controlled trials.
Lewsey JD; Leyland AH; Murray GD; Boddy FA
Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
[TBL] [Abstract][Full Text] [Related]
9. Methodological and ethical quality in phase III--breast cancer trials.
Thoma V; Bridoux V; Lefebure B; Wattiez A; Nisand I; Tuech JJ
Med Law; 2009 Dec; 28(4):637-48. PubMed ID: 20157975
[TBL] [Abstract][Full Text] [Related]
10. [Pre-randomisation in study designs: getting past the taboo].
Schellings R; Kessels AG; Sturmans F
Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2053-6. PubMed ID: 18837179
[TBL] [Abstract][Full Text] [Related]
11. Protocol for a systematic scoping review of reasons given to justify the performance of randomised controlled trials.
Dewar B; Fedyk M; Jurkovic L; Chevrier S; Rodriguez R; Kitto SC; Saginur R; Shamy M
BMJ Open; 2019 Jul; 9(7):e027575. PubMed ID: 31350242
[TBL] [Abstract][Full Text] [Related]
12. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
[TBL] [Abstract][Full Text] [Related]
13. Ethical issues in the design and conduct of randomised controlled trials.
Edwards SJ; Lilford RJ; Braunholtz DA; Jackson JC; Hewison J; Thornton J
Health Technol Assess; 1998 Dec; 2(15):i-vi, 1-132. PubMed ID: 10194615
[No Abstract] [Full Text] [Related]
14. Reporting of ethical requirements in phase III surgical trials.
Bridoux V; Schwarz L; Moutel G; Michot F; Herve C; Tuech JJ
J Med Ethics; 2014 Oct; 40(10):687-90. PubMed ID: 23959837
[TBL] [Abstract][Full Text] [Related]
15. Adaptive designs, informed consent, and the ethics of research.
Pullman D; Wang X
Control Clin Trials; 2001 Jun; 22(3):203-10. PubMed ID: 11384785
[TBL] [Abstract][Full Text] [Related]
16. Reconsidering the ethics of sham interventions in an era of emerging technologies.
Niemansburg SL; van Delden JJ; Dhert WJ; Bredenoord AL
Surgery; 2015 Apr; 157(4):801-10. PubMed ID: 25704427
[TBL] [Abstract][Full Text] [Related]
17. Reconsidering 'ethics' and 'quality' in healthcare research: the case for an iterative ethical paradigm.
Stevenson FA; Gibson W; Pelletier C; Chrysikou V; Park S
BMC Med Ethics; 2015 May; 16():21. PubMed ID: 25952678
[TBL] [Abstract][Full Text] [Related]
18. Ethical and legal issues in emergency research: barriers to conducting prospective randomized trials in an emergency setting.
Morrison CA; Horwitz IB; Carrick MM
J Surg Res; 2009 Nov; 157(1):115-22. PubMed ID: 19765724
[TBL] [Abstract][Full Text] [Related]
19. A Kantian claim permitting the randomised clinical trial.
Katz P
Princet J Bioeth; 2001; 4():109-23. PubMed ID: 12166461
[TBL] [Abstract][Full Text] [Related]
20. Methodological quality and reporting of ethical requirements in phase III cancer trials.
Tuech JJ; Pessaux P; Moutel G; Thoma V; Schraub S; Herve C
J Med Ethics; 2005 May; 31(5):251-5. PubMed ID: 15863678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
